Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.
Category: Eli Lilly and Company
-
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance
The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.
-
Jeff Bezos, Jay Powell, Serena Williams and More Will Speak at the DealBook Summit
The conference on Dec. 4 will bring together the biggest names in business, politics and culture.
-
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
-
U.S. Unveils Price Limits for 10 Costly or Common Medications
The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
-
U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations
The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
-
New Drug Approved for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
-
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
-
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
-
F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
-
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.
-
How Much Do Ozempic and Wegovy Cost? Not What You Think.
Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.